CenExel ACT — Anaheim, California

CenExel ACT is a clinical research site located in Anaheim, California, United States 92801.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

CenExel ACT has participated in 10 clinical trials with 2 currently active.

Therapeutic areas: Healthy, Atopic Dermatitis, Diabetes Mellitus, Type 2.

Sponsors: Eli Lilly and Company, Alzheimer's Disease Expert Lab (ADEL), Inc..

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CenExel ACT?

CenExel ACT has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CenExel ACT conducted?

CenExel ACT has 10 clinical trials on record, with 2 currently active. Their work covers Healthy, Atopic Dermatitis, Diabetes Mellitus, Type 2.

Is CenExel ACT accredited by Crixeo Health?

CenExel ACT has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CenExel ACT?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.